Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDMB study of busulfan therapeutic drug monitoring before autologous transplant in central nervous system lymphoma
jRCT1031260184Recruiting
- Sponsor
- University of Tsukuba Hospital
- Start
- Jul 2026
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of busulfan and thiotepa in central nervous system lymphoma, sponsored by University of Tsukuba Hospital. Primary endpoint: Grade 3 or higher liver dysfunction. Started Jul 2026; status: recruiting.
02
Drugs
busulfanthiotepa
03
Conditions
central nervous system lymphoma
Beyond the preview
Go deeper on jRCT1031260184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031260184.